CD8+ T cells specific for the HLA-A*0201-restricted IGRP265−273 peptide were previously discussed as potential effectors of the islet destructive process in patients with type 1 diabetes and in HLA transgenic mice (20–22). The gene discussed is CD8A; the disease is type 1 diabetes mellitus.